Mayo Clinic, Corindus Vascular Robotics team up to develop 'telestenting'
Corindus Vascular Robotics and Mayo Clinic have partnered to conduct a preclinical study meant to evaluate the viability of “telestenting,” having a remote clinician complete a robot-assisted percutaneous coronary intervention (PCI).
As telehealth platforms offering basic care become more common in rural areas, Carindus and Mayo Clinic are taking another step forward, exploring if remote physicians can perform robot-assisted PCIs. The multi-year partnership aims to initially test the “telestenting” program on PCIs but hopes to expand to the remote treatment of endovascular and strokes.
“We are delighted to work on critical research for remote robotics with Mayo Clinic,” Corindus CEO and president Mark Toland said in a release. “While PCI is the initial focus for this development program, our long-term goal is to extend this capability to the remote treatment of endovascular disease and stroke. Corindus is committed to developing a high tech cardiovascular model that improves efficiency, integrates the latest technology, and ultimately improves patient care. Telestenting is at the core of this strategy."
Read the full story below:
Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.